Additional file 3: of Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer

Table S3. Patient characteristics. The table shows the characteristics of the 73 patients included in the study. Abbreviations: ER Estrogen receptor, HER2 Human epidermal growth factor receptor 2, ID Invasive ductal, IL Invasive lobular, NA Not available, PR Progesterone receptor, ECOG Eastern Cooperative Oncology Group (as defined by Oken et al. [24]). (XLSX 14 kb)附表S3 患者特征。本附表展示了本研究纳入的73例患者的临床特征。缩写说明：ER（雌激素受体，Estrogen receptor）、HER2（人表皮生长因子受体2，Human epidermal growth factor receptor 2）、ID（浸润性导管癌，Invasive ductal）、IL（浸润性小叶癌，Invasive lobular）、NA（无可用数据，Not available）、PR（孕激素受体，Progesterone receptor）、ECOG（东部肿瘤协作组评分，Eastern Cooperative Oncology Group，依据Oken等[24]的定义）。（XLSX格式，文件大小14 KB）